![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.345, 2002-01, pp. : 8-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Inhaled anti-inflammatory drugs for asthma: better care at lower cost
Inpharma, Vol. 1, Iss. 1263, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Inhaled anti-inflammatory drugs for asthma: better care at lower cost
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 288, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
CHF programme: better care, better outcomes
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 299, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Fluticasone propionate better value than flunisolide in asthma
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 245, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Better advantage with fluticasone propionate in persistent asthma
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 291, 2000-01 ,pp. :